Regarding the efficacy of EGFR‐targeted cLNPs, a significantly inhibited tumor growth by 90% was observed in T‐sgSOX2‐cLNPs (T‐sgSOX2) compared to I‐sgNC‐cLNPs (I‐sgSOX2) treated mice. This evidence concerns the gene EGFR and neoplasm.